Dr. Mahesh Kate

Biography

Mahesh Kate is an Associate Professor in the Department of Medicine at the University of Alberta and a Neurologist with Alberta Health Services. His research focuses on secondary stroke prevention, developing sustainable interventions aimed at improving outcomes for stroke patients. He has co-designed the SPRINT INDIA study, which enrolled over 4,000 patients across 31 centers and demonstrated that education can significantly improve treatment compliance. Dr. Kate also serves as the Co-Principal Investigator for the CoPrime trial, which investigates the effectiveness of combined Clopidogrel and Aspirin therapy in patients who undergo reperfusion therapies for acute ischemic stroke. His work also includes employing remote ischemic conditioning (RIC) to enhance treatment efficacy, alongside pioneering observational studies that explore neurophysiological recovery post-stroke. He leads the Young Stroke Prevention Clinic at the Kaye Edmonton Clinic, where he examines stroke risk across varying demographics, with a keen interest in age and sex differences in stroke outcomes.

Research Interests

Experience